(Q52863123)

9 May 2018

reason for preferred rank

meta-analysis

0 references

title

Lithium Augmentation in Antidepressant-Resistant Patients a Quantitative Analysis (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

6 December 2022

Lithium augmentation in antidepressant-resistant patients. A quantitative analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836411

6 December 2022

3

Goodwin GM

1 reference

9 May 2018

author name string

M. P. Austin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836411

6 December 2022

F. G. Souza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836411

6 December 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

9 May 2018

full work available at URL

number of pages

5

1 reference

based on heuristic

inferred from page(s)

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000030397

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

British Journal of Psychiatry

6 December 2022

published in

1 reference

9 May 2018

volume

159

1 reference

9 May 2018

page(s)

510-514

1 reference

9 May 2018

A potential clinical use for methylphenidate with tricyclic antidepressants.

cites work

1

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Treatment of depressions resistant to tricyclic antidepressants, related drugs or MAO-inhibitors by lithium addition: review of the literature

6 December 2022

2

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

The benefit of lithium carbonate adjunct in refractory depression--fact or fiction?

6 December 2022

3

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Confidence--and clinical importance--in research findings

6 December 2022

7

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN

6 December 2022

10

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Variability of response to lithium augmentation in refractory depression

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin

6 December 2022

12

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders

6 December 2022

14

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression

6 December 2022

15

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Statistical aspects of the analysis of data from retrospective studies of disease

6 December 2022

16

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects.

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Beta blockade during and after myocardial infarction: an overview of the randomized trials

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.

6 December 2022

22

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Treatment of previously intractable depressions with tranylcypromine and lithium

6 December 2022

23

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

6 December 2022

25

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

6 December 2022

26

1 reference

https://api.crossref.org/works/10.1192/BJP.159.4.510

6 December 2022

Identifiers

1 reference

9 May 2018

1 reference

9 May 2018